NO155496C - Fremgangsmaate for fremstilling av glykopeptidantibiotikum a/16686. - Google Patents

Fremgangsmaate for fremstilling av glykopeptidantibiotikum a/16686.

Info

Publication number
NO155496C
NO155496C NO800869A NO800869A NO155496C NO 155496 C NO155496 C NO 155496C NO 800869 A NO800869 A NO 800869A NO 800869 A NO800869 A NO 800869A NO 155496 C NO155496 C NO 155496C
Authority
NO
Norway
Prior art keywords
glycopeptid
antibiotics
preparing
procedure
preparing glycopeptid
Prior art date
Application number
NO800869A
Other languages
English (en)
Norwegian (no)
Other versions
NO800869L (no
NO155496B (no
Inventor
Bruno Cavalleri
Hermes Pagani
Giancarlo Volpe
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of NO800869L publication Critical patent/NO800869L/no
Publication of NO155496B publication Critical patent/NO155496B/no
Publication of NO155496C publication Critical patent/NO155496C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10GCRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
    • C10G49/00Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00
    • C10G49/02Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00 characterised by the catalyst used
    • C10G49/08Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00 characterised by the catalyst used containing crystalline alumino-silicates, e.g. molecular sieves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J29/00Catalysts comprising molecular sieves
    • B01J29/04Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00Silicon; Compounds thereof
    • C01B33/20Silicates
    • C01B33/26Aluminium-containing silicates, i.e. silico-aluminates
    • C01B33/28Base exchange silicates, e.g. zeolites
    • C01B33/2807Zeolitic silicoaluminates with a tridimensional crystalline structure possessing molecular sieve properties; Isomorphous compounds wherein a part of the aluminium ore of the silicon present may be replaced by other elements such as gallium, germanium, phosphorus; Preparation of zeolitic molecular sieves from molecular sieves of another type or from preformed reacting mixtures
    • C01B33/2884Zeolitic silicoaluminates with a tridimensional crystalline structure possessing molecular sieve properties; Isomorphous compounds wherein a part of the aluminium ore of the silicon present may be replaced by other elements such as gallium, germanium, phosphorus; Preparation of zeolitic molecular sieves from molecular sieves of another type or from preformed reacting mixtures the aluminium or the silicon in the network being partly replaced
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425Catalysts; their physical properties
    • C07C1/043Catalysts; their physical properties characterised by the composition
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425Catalysts; their physical properties
    • C07C1/043Catalysts; their physical properties characterised by the composition
    • C07C1/0435Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425Catalysts; their physical properties
    • C07C1/043Catalysts; their physical properties characterised by the composition
    • C07C1/0435Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof
    • C07C1/044Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof containing iron
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10GCRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
    • C10G35/00Reforming naphtha
    • C10G35/04Catalytic reforming
    • C10G35/06Catalytic reforming characterised by the catalyst used
    • C10G35/065Catalytic reforming characterised by the catalyst used containing crystalline zeolitic molecular sieves, other than aluminosilicates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2529/00Catalysts comprising molecular sieves
    • C07C2529/04Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites, pillared clays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045Actinoplanes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/827Actinoplanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Geology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO800869A 1979-04-07 1980-03-25 Fremgangsmaate for fremstilling av glykopeptidantibiotikum a/16686. NO155496C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7912298 1979-04-07

Publications (3)

Publication Number Publication Date
NO800869L NO800869L (no) 1980-10-08
NO155496B NO155496B (no) 1986-12-29
NO155496C true NO155496C (no) 1987-04-08

Family

ID=10504421

Family Applications (1)

Application Number Title Priority Date Filing Date
NO800869A NO155496C (no) 1979-04-07 1980-03-25 Fremgangsmaate for fremstilling av glykopeptidantibiotikum a/16686.

Country Status (30)

Country Link
US (2) US4303646A (xx)
JP (2) JPS5697237A (xx)
AR (1) AR222217A1 (xx)
AT (1) AT370130B (xx)
AU (2) AU533951B2 (xx)
BE (1) BE882632A (xx)
CA (1) CA1142866A (xx)
CH (1) CH655515B (xx)
DE (1) DE3013246A1 (xx)
DK (1) DK149336C (xx)
ES (1) ES490236A0 (xx)
FI (1) FI65630C (xx)
FR (1) FR2452931A1 (xx)
GR (1) GR67279B (xx)
HK (1) HK23584A (xx)
HU (1) HU181534B (xx)
IE (1) IE49327B1 (xx)
IL (1) IL59704A (xx)
IT (1) IT1212411B (xx)
LU (1) LU82327A1 (xx)
MX (1) MX5958E (xx)
NL (1) NL192989C (xx)
NO (1) NO155496C (xx)
NZ (1) NZ193357A (xx)
PH (1) PH17230A (xx)
PT (1) PT71064A (xx)
SE (1) SE441188B (xx)
SG (1) SG22687G (xx)
YU (1) YU41917B (xx)
ZA (1) ZA801629B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3163075D1 (en) 1980-08-16 1984-05-17 Lepetit Spa Antibiotic a/16686 factor a2, the process for the preparation thereof, and the co-produced antibiotic a/16686 factors a1 and a3
US4375513A (en) * 1980-12-18 1983-03-01 Eli Lilly And Company Biologically pure culture of Actinoplanes missouriensis
US4859599A (en) * 1984-10-11 1989-08-22 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
US4613503A (en) * 1984-10-11 1986-09-23 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
GB8624806D0 (en) * 1986-10-16 1986-11-19 Pfizer Ltd Glycopeptide antibiotic
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
GB8729989D0 (en) * 1987-12-23 1988-02-03 Lepetit Spa Novel hydrogenated derivatives of antibiotic a/16686
GB8808658D0 (en) * 1988-04-13 1988-05-18 Lepetit Spa Aglycons of a/16686 antibiotics
WO2001053533A2 (en) * 2000-01-21 2001-07-26 Kosan Biosciences, Inc. Method for cloning polyketide synthase genes
US7257562B2 (en) * 2000-10-13 2007-08-14 Thallion Pharmaceuticals Inc. High throughput method for discovery of gene clusters
DE60109952T2 (de) * 2000-10-13 2006-02-09 Ecopia Biosciences Inc., Saint-Laurent Ramoplaninbiosynthesegenkluster
US20030211567A1 (en) * 2001-07-24 2003-11-13 Ecopia Biosciences, Inc. Compositions, methods and systems for discovery of lipopeptides
JP2005529852A (ja) * 2002-03-08 2005-10-06 ビクロン・フアーマシユーチカルズ・インコーポレーテツド ラモプラニン−様アミド誘導体の製造法
CA2430580A1 (en) * 2002-04-17 2003-09-04 Ecopia Biosciences Inc. Specialized dual condensation/epimerization domain in non-ribosomal peptide synthetase systems
CA2488803C (en) * 2002-06-06 2013-08-13 Vicuron Pharmaceuticals Inc. Use of ramoplanin to treat diseases associated with the use of antibiotics
AU2003274927A1 (en) * 2002-08-23 2004-03-11 Genome Therapeutics Corporation Methods and reagents for preventing bacteremias
US20040127403A1 (en) * 2002-09-06 2004-07-01 Francesco Parenti Methods for treating and preventing Gram-positive bacteremias
CA2523573A1 (en) * 2003-04-25 2004-11-11 Oscient Pharmaceuticals Corporation Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility
CA2945768A1 (en) 2014-04-16 2015-10-22 Nanotherapeutics, Inc. Methods of treatment of c. difficile spores with ramoplanin
US20180002741A1 (en) 2016-07-01 2018-01-04 The United States Of America As Represented By The Department Of Veterans Affairs Method of diagnosis and treating gastrointestinal and neurological diseases associated with species of genus clostridium

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790627A (fr) * 1971-10-27 1973-04-27 Lilly Co Eli L'antibiotique a477 et son procede de preparation
GB1458512A (en) * 1973-11-22 1976-12-15 Lepetit Spa Antibiotic substance
US4038383A (en) * 1975-01-17 1977-07-26 Pfizer Inc. Mixture of antibiotics produced by a species of actinoplanes
US4001397A (en) * 1975-08-11 1977-01-04 Pfizer Inc. Antibiotic compound 41,012
US4115552A (en) * 1976-04-19 1978-09-19 Eli Lilly And Company Factor A and B of antibiotic A-4696
US4169887A (en) * 1978-02-21 1979-10-02 Pfizer Inc. Antibiotics produced by species of actinoplanes
JPS54135703A (en) * 1978-04-11 1979-10-22 Dainippon Pharmaceut Co Ltd Antibiotic ab-102 and preparation thereof

Also Published As

Publication number Publication date
JPS62282579A (ja) 1987-12-08
SE8002601L (sv) 1980-12-01
ATA187480A (de) 1982-07-15
SE441188B (sv) 1985-09-16
NL192989C (nl) 1998-07-03
YU93580A (en) 1983-06-30
AR222217A1 (es) 1981-04-30
FI800881A (fi) 1980-10-08
NL192989B (nl) 1998-03-02
MX5958E (es) 1984-09-06
DK149336B (da) 1986-05-05
AU5703680A (en) 1980-10-09
FI65630B (fi) 1984-02-29
JPS6320514B2 (xx) 1988-04-27
HK23584A (en) 1984-03-23
LU82327A1 (fr) 1981-12-02
PT71064A (en) 1980-05-01
ES8103170A1 (es) 1981-02-16
NO800869L (no) 1980-10-08
CA1142866A (en) 1983-03-15
AU535727B2 (en) 1984-04-05
FI65630C (fi) 1984-06-11
AT370130B (de) 1983-03-10
IE49327B1 (en) 1985-09-18
ZA801629B (en) 1981-03-25
DE3013246A1 (de) 1980-10-16
AU5903680A (en) 1980-12-11
CH655515B (xx) 1986-04-30
YU41917B (en) 1988-02-29
BE882632A (fr) 1980-10-03
IE800697L (en) 1980-10-07
FR2452931A1 (fr) 1980-10-31
NL8001982A (nl) 1980-10-09
HU181534B (en) 1983-10-28
DK140080A (da) 1980-10-08
SG22687G (en) 1989-07-07
ES490236A0 (es) 1981-02-16
NZ193357A (en) 1982-12-07
IL59704A0 (en) 1980-06-30
FR2452931B1 (xx) 1983-07-01
IT1212411B (it) 1989-11-22
AU533951B2 (en) 1983-12-22
JPS5697237A (en) 1981-08-05
IL59704A (en) 1983-11-30
NO155496B (no) 1986-12-29
JPS6251274B2 (xx) 1987-10-29
PH17230A (en) 1984-07-03
DK149336C (da) 1986-10-13
IT8021162A0 (it) 1980-04-03
DE3013246C2 (xx) 1987-11-19
US4303646A (en) 1981-12-01
GR67279B (xx) 1981-06-26
US4328316A (en) 1982-05-04

Similar Documents

Publication Publication Date Title
NO167674C (no) Fremgangsmaate for fremstilling av et plasmid.
SE8100368L (sv) Forfarande for framstellning av immunogammaglobulin
NO155496C (no) Fremgangsmaate for fremstilling av glykopeptidantibiotikum a/16686.
DK537780A (da) 1,8-naphthyridin-derivater
NO148959C (no) Fremgangsmaate ved fremstilling av tumor-motvirkende antracyklinglykosidantibiotika, betegnet ma 144
SE8008339L (sv) 24,24-difluoro-1alfa,25-dihydroxikolekalciferol
NO800627L (no) Fremgangsmaate for fremstilling av lateks.
IT1151077B (it) 24,24-difluoro-25-idrossicolecalciferolo
FI803727L (fi) 2,3-indolidionderivat
NO801659L (no) Fremgangsmaate ved fremstilling av 10,11-dihydro-5h-dibenzo-(a,d,)-cyclohepten-5,10-iminer
ES508064A0 (es) "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES495819A0 (es) Procedimiento de preparar derivados 1,2,4-oxadiazolin-5-oni-cos
NO157063C (no) FremgangsmŸte for fremstilling av etylen-propylen-blokk-sampolymerer.
SE426947B (sv) Forfarande for framstellning av 3,5,5-trimetyl-hexanoyl-ferrocen
NO774503L (no) Fremgangsmaate for fremstilling av oktahydro-indolo(2,3,a)-chinoliziner
FI801473A (fi) Framstaellningsfoerfarande foer 5-merkapto-1,2,3-triazoler
FI803038A (fi) Framstaellning av 2,5-diketoglukonsyra
GB2062628B (en) 1,2,4-oxadiazine derivatives
NO802372L (no) Fremgangsmaate for fremstilling av 2-isopropylamino-pyrimidin
FI792770A (fi) Foerfarande foer framstaellning av 1,2,3-tiadiazol-5-ylkarbamider
FI800106A (fi) Foerfarande foer separering av d,1 2-(6-metoxi-2-naftyl)propionsyra
BE883295A (fr) 6,7-secoergolines
NO146873C (no) Fremgangsmaate til fremstilling av depsipeptidantibiotikum l 13365.
FI803041A (fi) Framstaellning av 2-oxo-dihydrobenso/d/1,3/oxaziner
NO154881C (no) Fremgangsmaate ved fremstilling av 5(6)-thiocyan-benzimidazolderivater.